# Evaluation of Anti-Inflammatory Treatment in Dry Eye Patients

> **NCT01276223** · PHASE2 · COMPLETED · sponsor: **Alcon Research** · enrollment: 722 (actual)

## Conditions studied

- Dry Eye Disease

## Interventions

- **DRUG:** Difluprednate 0.05% ophthalmic emulsion
- **OTHER:** Difluprednate vehicle

## Key facts

- **NCT ID:** NCT01276223
- **Lead sponsor:** Alcon Research
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-02
- **Primary completion:** 2012-01
- **Final completion:** 2012-01
- **Target enrollment:** 722 (ACTUAL)
- **Last updated:** 2013-03-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01276223

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01276223, "Evaluation of Anti-Inflammatory Treatment in Dry Eye Patients". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT01276223. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*